List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

AL-S Pharma Company

AL-S Pharma AG develops AP-101, a human monoclonal antibody targeting misfolded SOD1 for the treatment of ALS.


Connections

Headquarters: Schlieren, Zurich, Switzerland, Europe
Employee Number: 1-10
Industry: Cell, Gene & Biologics Therapeutics
Founded Date: 2016-01-01
Super Industry: Biopharma & Life Science Tools
Investors: Neurimmune Holding, TVM Capital Life Science
Ipo Status: private
City: Schlieren
Region: Zurich
Country: Switzerland